slider

Hepatobiliary Cancers Research Working Group

For More Information

Hepatobiliary Cancers DOT Progress Report

Support the Hepatobiliary Cancers DOT

Hepatobiliary cancers include tumors that start in cells of the liver, bile ducts, and gallbladder. The Hepatobiliary Group includes 14 members who conduct research to better understand and treat these tumors:

  • Find defective cellular functions that cause hepatobiliary cancers
  • Develop effective treatments
  • Recognize and understand the inherited factors that increase risk

Leadership:

Robin Kim
Robin Kim, MD

Research that Makes a Difference

From bench to bedside, the Hepatobiliary Group works on research projects designed to improve the quality of life of cancer patients and their families. Below is a sample of current research projects:

  • Tissue Banking for Chronic Disease Research:
    • To better develop treatments for hepatobiliary cancers, the Research Group collects, processes, and stores blood and tissue samples. By having a large collection of samples, cancer researchers can study cellular activity on a molecular level to better understand why and how cancer cells develop and spread. This may lead to more effective treatments.
  • Natural History of Cholangiocarcinoma
    • Certain diseases such as primary sclerosing cholangitis and inflammatory bowel disease are risk factors for developing biliary cancers. When researchers study tissue from patients who have these conditions, they can track changes that may lead to cancer. Understanding how the disease grows can help researchers develop diagnostic tests so biliary cancer can be caught and treated earlier. This may also lead to new drugs to prevent or treat biliary cancer.

Donate to the Hepatobiliary Cancers Working Group now >>>